SBI may fund $1B for Sun Pharma's $12B Organon buy

SBI may commit $1 billion to fund Sun Pharma’s $12 billion acquisition of Organon. This strategic move bolsters Sun Pharma’s global footprint with $12B deal size and $1B SBI backing. The acquisition could significantly enhance product portfolio and overseas revenue. Regulatory approvals remain pending.

📊 STOCKS: SUNPHARMA | 🏢 SECTOR: Pharma | #HIGHIMPACT #Acquisition